体验预临床阿尔茨海默病:面对可能的诊断
Opinion: STAT+: ‘What will I do with the time I have left?’: What it’s like to find out you might develop Alzheimer’s
贾森·卡拉维什教授描述了预临床阿尔茨海默病患者的体验,强调了早期诊断和干预的重要性。原文指出,尽管目前尚无治疗方法,但关注该病的早期形式有助于预防和干预。
By Jason Karlawish
Nov. 13, 2026
Karlawish is a professor of medicine, medical ethics, health policy, and neurology at the University of Pennsylvania’s Perelman School of Medicine, co-director of the Penn Memory Center, and executive producer of the “Age of Aging” podcast. He writes Neurotransmissions, a STAT column about the new era of dementia.
This is the second of two pieces about the experiencing of pre-clinical Alzheimer’s. Read the first here.
In 1976, at the dawn of the modern Alzheimer’s era, the neurologist Robert Katzman, champion of efforts to extract Alzheimer’s from senility and “normal aging,” concluded his short essay “The prevalence and malignancy of Alzheimer disease” with this notably qualified call to action:
“In focusing attention on the mortality associated with Alzheimer disease, our goal is not to find a way to prolong the life of severely demented persons, but rather to call attention to our belief that senile as well as presenile forms of Alzheimer are a single disease, a disease whose etiology must be determined, whose course must be aborted, and ultimately a disease to be prevented.”
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
来源:STAT 主站 · statnews.com